This Is What Surprised Me Most About the Google I/O AI Shopping Feature
An AI fashion tool was not on my Google I/O bucket list. At Google's annual I/O developers conference, the company introduced a number of Gemini AI updates, many of which are coming to Search and, notably, to our online shopping experiences. The new AI shopping feature lets you virtually "try on" different articles of clothing by using a photo of your body and imagining what it may look like on you.
Google built a custom image generation model to power its new feature. It's a simple idea: Google's AI takes your input image of your body and the input image of the garment, and the AI combines them. The actual process behind it is more complicated, surely. But in the live demo, it seemed to work flawlessly. The virtual try on feature is available today in the US, with more visual shopping and AI agentic updates coming soon.
I was very intrigued when I saw the live demo. I shop online for nearly everything I need, and I have been fooled many times by mis-imagining how clothing I see on models would look on me. But I'm an AI reporter, and I spend a lot of time worrying about the privacy implications of image and video tools, so I was skeptical, too.
Read more: Everything Announced at Google I/O 2025
I reached out to Google after the keynote to ask about the privacy policies around this new feature. A Google spokesperson said: "Your uploaded photo is never used beyond trying things on virtually, nor is your photo used for training purposes. It is not shared with other Google products, services or third parties, and you can delete or replace it at any time."
I was jaw-droppingly, pleasantly surprised by this. In the age of AI, tech companies are typically so data-hungry that a source of data like this seemed like a no-brainer for Google to use. Google spent a decent chunk of time during I/O showing off its new AI image and video tools, and human-generated photos like these would be useful for future model improvements.
Tech and fashion companies have been trying to work at these problem for years -- my CNET colleague Katie Collins wrote about one dress-sizing app all the way back in 2012, and Amazon's integrated AI for its fashion sales in recent years, too.
This fashion model, as Vidhya Srinivasan, Google's vice president and general manager of ads and commerce, called it during the keynote, has "a deep understanding of the human body." We'll have to test it out to see if it really works for all body types and sizes. AI image generators, especially early ones from Google, aren't always great when it comes to diversity. But I'm willing to give Google a chance since it won't use my pictures to automatically train its AI models.
As much as I want to believe Google has given us a 2025 version of Cher's closet from Clueless, I'm still a little skeptical. There's no guarantee that the AI version of yourself Google generates will actually reflect how the clothing looks on you in real life. But maybe this is a potentially good use of AI, instead of filling the internet with slop.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
David E. Kelley says new ending for ‘Presumed Innocent' on Apple TV+ ‘wasn't mandatory'
David E. Kelley adapted Scott Turow's bestseller Presumed Innocent as an eight-episode series for Apple TV+ last year. Between the book and the 1990 movie adaptation, the original revelation of the murderer might no longer be a surprise. So, Kelley chose a different character to be the killer in his season finale. 'It wasn't mandatory,' Kelley told Gold Derby on the red carpet at Apple TV+'s FYC space at the Hollywood Athletic Club. 'I was open to the idea that it could still be the same killer but we kind of let the story speak to us. As it was unfolding, we settled on the route we took.' More from GoldDerby Sharon Horgan, Anne-Marie Duff, Fiona Shaw, and every 'Bad Sisters' Emmy acting submission How David Bowie inspired Eddie Redmayne's 'Day of the Jackal' transformations D'Arcy Carden on her 'dream come true' joining 'The Handmaid's Tale' and Phoebe's 'different Aunt energy' Jake Gyllenhaal plays Rusty Sabich, a lawyer accused of slaying his colleague, Caroline Polhemus (Renate Reinsve), with whom he was having an affair. Rusty's nemesis, Tommy Molto (Peter Sarsgaard), prosecutes Rusty despite a clear conflict of interest. Though the killer is only revealed to Rusty's family, Sarsgaard suspects the ending still validates Tommy's suspicions. Apple TV+ 'I think Tommy always knew who was involved and he was correct about that,' Sarsgaard said, without giving away the spoiler. 'He wasn't incorrect [about] the person he suspected who was covering something.' Now that all eight episodes are available to stream, it's well-known the show ends differently. Other updates Kelley made to Turow's 1987 debut novel included combining characters and incorporating 2024 elements like DNA evidence and cellphone technology. 'I think what was more important is that we declared ourselves out of the gate that we were going to take departures from the underlying material,' Kelley said. 'So at least the viewer would not feel comfortable that they knew the outcome.' Bill Camp plays Rusty's lawyer, Raymond Horgan, who is so troubled by the case that he has nightmares about Rusty committing the murder. Though Raymond is unaware of the final revelation, Camp said the damage is done regardless of who did it. 'I think he'd find it heartbreaking,' Camp said. 'The darkness that everyone's living in now, not knowing who that murderer is except for that family, I think it would be heartbreaking for everyone to find out.' Finding out the new identity of the killer in Episode 8 reminded Sarsgaard of another mystery show he appeared in. In Season 3 of The Killing, Sarsgaard recalled his costar being devastated to find out he was the killer. This moment drove home for Sarsgaard the nature of episodic television with ongoing writers' rooms. 'We got the final episode, he came up to my trailer really upset,' Sarsgaard said. 'He said, 'Oh, it's me. I'm the killer.' I thought, 'F--k.' Movies is just all preparation from the beginning.' Apple TV+ Kelley acknowledged that he was asking a lot of his lead actor. Viewers would judge Rusty for cheating on his wife, Barbara (Ruth Negga), and possibly suspect him of murder — yet he remains the protagonist of the series. 'He had a heavy lift in this series,' Kelley said of Gyllenhaal. 'A writer can put that on the page all he wants but it's up to the actor to inhabit those qualities to make the audience care. So I think viewers were condemning Rusty on a lot of fronts but rooting for him just the same.' Episodic directors said the series benefited from Gyllenhaal and Sarsgaard's real-life relationship. They are brothers-in-law, as Sarsgaard is married to Jake's sister, Maggie Gyllenhaal. Greg Yaitanes directed Episodes 3-7, culminating in the scene where Tommy cross-examines Rusty. 'They can practice,' Yaitanes said. 'They were roommates as well so they were staying with each other so they just worked at that scene. There was this added intangible benefit of their trust and closeness that they got into every scene.' Anne Sewitsky directed the first two episodes and the final one. She also benefited from Sarsgaard and Gyllenhaal's familial friendship in her episodes. 'There was kind of a shortcut or shorthand into the way we played with those scenes,' Sewitsky said. 'They like to throw things around. I love that so we were doing a lot of improv and we were adding a lot of stuff.' Best of GoldDerby Samantha Hanratty on Misty stepping 'into her own' in 'Yellowjackets' Season 3: 'She is a lot more useful than I think a lot of people give her credit for' How Madeline Brewer gets the power back in the final seasons of 'You' and 'The Handmaid's Tale' 'I fully expected to be killed off!' Helen Mirren on her twin roles in '1923' and 'MobLand' Click here to read the full article.
Yahoo
21 minutes ago
- Yahoo
MaxLinear and Comtrend Announce Availability of EV Charging Station Powerline Data Modules
MaxLinear Technology enables Comtrend's powerline data modules to accelerate EV charger installations CARLSBAD, Calif., June 02, 2025--(BUSINESS WIRE)--MaxLinear, Inc. (Nasdaq: MXL) and Comtrend announced today the availability of ITU-T standards-based powerline data modules for EV Charging Stations (EVSE) backend communication, including data centers and smart parking extensions. Using MaxLinear technology (data-over-powerline), Comtrend's innovative powerline data module series collects and transfers data from power meters in EV charging infrastructure (EVSE) and IoT devices without the need for new cable installations. Comtrend leverages existing electrical powerlines for data communication, providing a scalable and hassle-free solution. This approach is particularly effective in underground concrete environments, where charging stations are frequently installed and other technologies lack reliability. Comtrend PM 1540 key benefits include: - No new wiring required – uses existing electrical wires for data transmission.- Lower latency, higher speeds, and greater stability than traditional methods.- Real-time connectivity.- Significant cost savings vs. LAN, Wi-Fi, or 4G solutions.- Simplified installation — reduced complexity, time, and no need for additional infrastructure.- Supports an electric wire domain of up to 250 nodes for large-scale deployments.- Strong signal transmission reaching up to 700 meters with up to 16 levels of signal repetition. For additional information on the Comtrend PM 1540: Watch the overview video Download the datasheet "The electric vehicle industry has grown at an unprecedented rate in recent years. We are thrilled to partner with Comtrend to accelerate the installation of EV charging stations, addressing the industry's needs and meeting the rapidly increasing demand," said Vikas Choudhary, Vice President of Connectivity and Storage Business at MaxLinear. Our product portfolio addresses a wide range of applications, including industrial IoT and Smart Grids, to proactively support the digital transformation of the industry." "Comtrend's Powerline Data Modules, powered by MaxLinear's cutting-edge technology, provide high-speed, secure, and reliable wired communication between EV charging stations and the smart grid," said Vaclav Slehofer, Managing Director and Vice President of Comtrend Europe. "By partnering with MaxLinear, we're bringing to market a cost-effective, easy-to-deploy and future-ready solution that ensures robust data connectivity for the evolving landscape of smart EV charging infrastructure." Why MaxLinear for EV Charging? The versatility of the technology standard provides ultra-fast and reliable network connectivity for a wide range of markets and applications. works over any wiring infrastructure – coax, telephone wire, powerline, or Power-over-Fiber (POF). achieves very low latency while enforcing comprehensive Quality of Service (QoS) and delivering Gigabit speeds under any packet size. MaxLinear's baseband processors and analog front-end chipsets are fully ITU compliant and deliver physical data rates up to 2Gbps, the fastest performance in the industry. Deploying MaxLinear for EV charging stations enables seamless interoperability, efficiency, and low-cost deployments. Visit for an overview of MaxLinear's solutions. Why Comtrend for EV Charging? Comtrend EVSE solutions provide enhanced interoperability, integrating with various EV charging brands and smart grid systems, ensuring compatibility across different platforms and technologies. Comtrend's products are available now. For a full overview of Comtrend solutions for EV charging and other industrial IoT solutions, click here for more information. About MaxLinear, Inc. MaxLinear, Inc. (Nasdaq: MXL) is a leading provider of radio frequency (RF), analog, digital, and mixed-signal integrated circuits for access and connectivity, wired and wireless infrastructure, and industrial and multimarket applications. MaxLinear is headquartered in Carlsbad, California. For more information, please visit About Comtrend Comtrend has over 30 years of experience delivering high-quality broadband networking solutions to Service Providers. Comtrend offers a comprehensive lineup of solutions ranging from gateways to networking devices that provide clever coverage to innovative use cases or difficult-to-reach areas. Contact us today to learn more at Comtrend is a Member of the HomeGrid Forum. Cautionary Note About Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning or implying future financial performance, statements relating to MaxLinear's technology and the functionality, performance and benefits of such technology, statements about the potential market opportunity and rate of growth for MaxLinear's technology, statements relating to the partnership between MaxLinear and Comtrend, statements by our Vice President of Connectivity and Storage business and statements by the Managing Director and Vice President of Comtrend Europe. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements and our future financial performance and operating results forecasts generally. Forward-looking statements are based on management's current, preliminary expectations and are subject to various risks and uncertainties. In particular, our future operating results are substantially dependent on our assumptions about market trends and conditions. Additional risks and uncertainties affecting our business, future operating results and financial condition include, without limitation; risks relating to the development, testing, and commercial introduction of new products and product functionalities; risks relating to our relationship with Comtrend; risks relating to our terminated merger with Silicon Motion and related arbitration and class action complaint and the risks related to potential payment of damages; the effect of intense and increasing competition; increased tariffs, export controls or imposition of other trade barriers; impacts of global economic conditions; the cyclical nature of the semiconductor industry; a significant variance in our operating results and impact on volatility in our stock price, and our ability to sustain our current level of revenue, which has previously declined, and/or manage future growth effectively, and the impact of excess inventory in the channel on our customers' expected demand for certain of our products and on our revenue; escalating trade wars, military conflicts and other geopolitical and economic tensions among the countries in which we conduct business; our ability to obtain or retain government authorization to export certain of our products or technology; risks related to the loss of, or a significant reduction in orders from major customers; costs of legal proceedings or potential violations of regulations; information technology failures; a decrease in the average selling prices of our products; failure to penetrate new applications and markets; development delays and consolidation trends in our industry; inability to make substantial research and development investments; delays or expenses caused by undetected defects or bugs in our products; substantial quarterly and annual fluctuations in our revenue and operating results; failure to timely develop and introduce new or enhanced products; order and shipment uncertainties; failure to accurately predict our future revenue and appropriately budget expenses; lengthy and expensive customer qualification processes; customer product plan cancellations; failure to maintain compliance with government regulations; failure to attract and retain qualified personnel; any adverse impact of rising interest rates on us, our customers, and our distributors and related demand; risks related to compliance with privacy, data protection and cybersecurity laws and regulations; risks related to conforming our products to industry standards; risks related to business acquisitions and investments; claims of intellectual property infringement; our ability to protect our intellectual property; risks related to security vulnerabilities of our products; use of open source software in our products; and failure to manage our relationships with, or negative impacts from, third parties. In addition to these risks and uncertainties, investors should review the risks and uncertainties contained in our filings with the Securities and Exchange Commission, including our Current Reports on Form 8-K, as well as the information to be set forth under the caption "Risk Factors" in MaxLinear's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025. All forward-looking statements are based on the estimates, projections and assumptions of management as of the date of this press release, and MaxLinear is under no obligation (and expressly disclaims any such obligation) to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise. View source version on Contacts MaxLinear, Inc. Press Contact:Debbie BrandenburgSr. Marketing Communications ManagerTel: +1 669.265.6083dbrandenburg@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
Boston Scientific ends TAVR sales; J&J shares Monarch robot data
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Boston Scientific said Wednesday it plans to end worldwide sales of its transcatheter aortic valve replacement systems, citing regulatory hurdles. The company will discontinue its Acurate Neo2 and Acurate Prime TAVR systems, which are sold in Europe, and will not pursue Food and Drug Administration approval for the devices. Boston Scientific said in a regulatory filing that the decision followed recent discussions with regulators, adding that the products faced increased requirements to maintain approvals in global markets and to obtain approvals in new regions. The company had told investors the 'path to approval in the U.S. was unclear and the approval requirements in Europe would be even greater,' Needham analyst Mike Matson wrote in a research note Wednesday. The decision followed Boston Scientific missing its primary endpoint in a trial comparing its Acurate Neo2 device to other TAVR systems. The Acurate business brought in about $200 million in sales last year, Matson wrote. 'Given the product's mixed clinical track record and complicated path to US approval, we're not surprised by Boston's choice to discontinue the product and redirect its time, effort, and dollars elsewhere,' J.P. Morgan analyst Robbie Marcus wrote in a research note. Marcus views the decision as the right strategy for Boston Scientific, even if the company takes a hit in the short term. Johnson & Johnson shared results of a study that found the company's Monarch bronchoscopy robot was able to reach small, peripheral lung nodules in more than 98% of cases. The robotic platform was able to locate and biopsy the nodules with a safety rate comparable to non-robotic bronchoscopy techniques, the company said in a Wednesday announcement. The TARGET study was published in Chest Journal on April 26 and was sponsored by J&J subsidiary Auris Health. The single-arm trial enrolled 679 people in the U.S., Canada and Hong Kong. Auris first received FDA clearance for the Monarch robot in 2018. J&J acquired the company a year later for $3.4 billion in cash. A software update for the system, intended to improve accuracy in reaching suspicious nodules, was cleared in March. Medtronic said Tuesday that a technology it is developing for its pulse oximeters was accepted into the FDA's Safer Technologies Program. The program is intended to support expedited development, assessment and review of devices that are expected to improve the safety of currently available devices. Medtronic is developing a technology to integrate patient- and sensor-specific data into oxygen saturation calculations used by its Nellcor pulse oximeters. Pulse oximeters have faced recent scrutiny by the FDA after studies have shown the devices may be less accurate for people with darker skin pigmentation. The agency issued a draft guidance in January updating testing recommendations for the devices, but it has not yet finalized the guidance. Last year, Medtronic agreed to provide labels and brochures to California hospital customers about the potential for flawed readings as part of a settlement with Roots Community Health, which sued 13 companies that make or sell pulse oximeters over the risk of disparities in treatment. Recommended Reading Edwards gains expanded TAVR label for asymptomatic patients Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
